High expression levels of AKT1 (p = 0.01), IFNGR1 (p = 0.01), and BRCA2 (p = 0.02) were predictive of early trabectedin treatment failure, irrespective of tumor grade. The gene discussed is BRCA2; the disease is neoplasm.